Molecular dynamics simulation analysis of the effect of T790M mutation on epidermal growth factor receptor protein

Xiao-Nu Peng1, Jing Wang2, Wei Zhang1

  • 1Department of Thoracic Surgery, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.

Oncology Letters
|August 10, 2017
PubMed

Insights

The T790M mutation in epidermal growth factor receptor (EGFR) causes treatment failure in non-small cell lung cancer. Molecular dynamics simulations reveal significant structural changes, informing the development of new kinase inhibitors.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Computational Chemistry

Background:

  • Non-small cell lung cancer (NSCLC) treatment failure is often linked to epidermal growth factor receptor (EGFR) kinase domain mutations.
  • The specific T790M mutation (threonine to methionine at position 790) confers resistance to tyrosine kinase inhibitors.

Purpose of the Study:

  • To investigate the atomic-scale architectural changes in EGFR kinase domains due to the T790M mutation.
  • To understand the structural basis of tyrosine kinase inhibitor resistance.

Main Methods:

  • Employed molecular dynamic simulations over 50-nanosecond runs.
  • Utilized the GROMOS force field and Gromacs tools for analysis.
  • Focused on the adenosine triphosphate (ATP) binding domain and active site of wild-type and mutant EGFR.

Main Results:

  • Observed considerable structural and parameter variations between wild-type and T790M mutant EGFR.
  • Detailed atomic-level insights into the conformational alterations within the kinase domain.

Conclusions:

  • The study elucidates structural changes in EGFR associated with T790M mutation.
  • Findings provide a foundation for designing novel kinase inhibitors effective against mutated EGFR, regardless of structural alterations.